Atria Wealth Solutions, Inc. Biomarin Pharmaceutical Inc Transaction History

Atria Wealth Solutions, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$74.43 - $92.22 $543,041 - $672,837	-7,296 Reduced 74.16%	2,542 $209,000
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $9,135 - $10,791	109 Added 1.12%	9,838 $859,000
Q4 2023 Feb 02, 2024	BUY	$76.22 - $98.51 $11,661 - $15,072	153 Added 1.6%	9,729 $938,000
Q3 2023 Nov 08, 2023	BUY	$85.07 - $94.48 $39,217 - $43,555	461 Added 5.06%	9,576 $847,000
Q2 2023 Aug 03, 2023	BUY	$86.68 - $100.3 $190,435 - $220,359	2,197 Added 31.76%	9,115 $790,000
Q1 2023 Aug 22, 2023	SELL	$87.74 - $117.27 $55,363 - $73,997	-631 Reduced 6.92%	8,484 $824,000
Q1 2023 Jun 14, 2023	SELL	$87.74 - $117.27 $137,400 - $183,644	-1,566 Reduced 18.46%	6,918 $672,000
Q1 2023 May 10, 2023	BUY	$87.74 - $117.27 $136,084 - $181,885	1,551 Added 22.37%	8,484 $824,000
Q4 2022 Aug 30, 2023	SELL	$80.93 - $108.63 $177,803 - $238,660	-2,197 Reduced 24.1%	6,918 $715,000
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $13,029 - $17,489	-161 Reduced 2.27%	6,933 $717,000
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $264,883 - $312,534	-3,224 Reduced 31.25%	7,094 $602,000
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $157,684 - $191,591	2,206 Added 27.19%	10,318 $855,000
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $602,559 - $751,901	8,112 New	8,112 $625,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.